Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)-Reference-Cited by-同舟云学术

Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)

Published:2014-03-10 Issue:1 Volume:6 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Mita Tomoya,Katakami Naoto,Shiraiwa Toshihiko,Yoshii Hidenori,Onuma Tomio,Kuribayashi Nobuichi,Osonoi Takeshi,Kaneto Hideaki,Kosugi Keisuke,Umayahara Yutaka,Yamamoto Tsunehiko,Matsumoto Kazunari,Yokoyama Hiroki,Tsugawa Mamiko,Gosho Masahiko,Shimomura Iichiro,Watada Hirotaka

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1186/1758-5996-6-35.pdf

Reference54 articles.

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339 (4): 229-234. 10.1056/NEJM199807233390404.

2. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16 (2): 434-444. 10.2337/diacare.16.2.434.

3. Wright RJ, Frier BM: Vascular disease and diabetes: is hypoglycaemia an aggravating factor?. Diabetes Metab Res Rev. 2008, 24 (5): 353-363. 10.1002/dmrr.865.

4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993, 329 (14): 977-986.

5. Jacob AN, Salinas K, Adams-Huet B, Raskin P: Weight gain in type 2 diabetes mellitus. Diabetes Obes Metab. 2007, 9 (3): 386-393. 10.1111/j.1463-1326.2006.00622.x.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling;International Journal of Molecular Sciences;2020-12-11

2. Clinical Utility of Carotid Ultrasonography in the Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies;Journal of Atherosclerosis and Thrombosis;2018-10-01

3. Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling;Stem Cells International;2018

4. Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis;Diabetes Therapy;2017-09-20

5. The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction;Cardiovascular Diabetology;2017-07-11